Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
233
Ten pairs of normal men were overfed by 5 MJ/d for 21 d with either a carbohydrate-rich or a fatrich diet (C- and F-group). The two subjects in each pair were requested to follow each other
throughout the day to ensure similar physical activity and were otherwise allowed to maintain
normal daily life. The increase in body weight, fat free mass and fat mass showed great variation,
the mean increases being 15 kg, 06 kg and 09 kg respectively. No signicant differences
between the C- and F-group were observed. Heat production during sleep did not change during
overfeeding. The RQ during sleep was 086 and 078 in the C- and F-group respectively. The
accumulated faecal loss of energy, DM, carbohydrate and protein was signicantly higher in the
C- compared with the F-group (30, 44, 69 and 51 % higher respectively), whereas the fat loss was
the same in the two groups. N balance was not different between the C- and F-group and was
positive. Fractional contribution from hepatic de novo lipogenesis, as measured by mass isotopomer
distribution analysis after administration of [1- 13C]acetate, was 020 and 003 in the C-group and
the F-group respectively. Absolute hepatic de novo lipogenesis in the C-group was on average
211 g per 21 d. Whole-body de novo lipogenesis, as obtained by the difference between fat mass
increase and dietary fat available for storage, was positive in six of the ten subjects in the C-group
(mean 332 (SEM 191) g per 21 d). The change in plasma leptin concentration was positively
correlated with the change in fat mass. Thus, fat storage during overfeeding of isoenergetic
amounts of diets rich in carbohydrate or in fat was not signicantly different, and carbohydrates
seemed to be converted to fat by both hepatic and extrahepatic lipogenesis.
Overfeeding: De novo lipogenesis: Energy expenditure: Leptin: Faecal loss
234
O. Lammert et al.
Height (cm)
Subjects
Mean
SEM
Mean
SEM
Mean
SEM
Mean
SEM
C1C10
F1F10
10
10
223
224
17
19
764
734
88
67
183
181
5
7
120
106
34
27
235
236
O. Lammert et al.
measuring the incorporation of [1- 13C]acetate in VLDLpalmitate over time (Hellerstein & Neese, 1993). For that
analysis 400 mg [1- 13C]acetate, 99 % enrichment, in approximately 50 ml water was given orally every 45 min from
10.0018.00 hours, and blood samples were obtained every
45 min from 10.0018.00 hours and at 19.00, 20.00 and
21.00 hours. The fractional hepatic DNL (F) was determined at each time point as described above, and the rate
constant determined by curve-tting of the time-course of F
to the equation F = A(1 - e -K s (t - L)), where A is the asymptotic value of F at isotopic steady-state, K s the rate constant for
VLDL synthesis, and L the lag-time for 13C-incorporation in
VLDL-fatty acids (Hellerstein & Neese, 1993). Total hepatic DNL was calculated as 075 K s F VLDL MM TG
(Hellerstein & Neese, 1993), where VLDL is the size of the
VLDL-pool (in mol), calculated as the mean of the nonfasting concentration of triacylglycerol in VLDL multiplied
by the plasma volume (assumed to be 004 times the body
weight), and MM TG set at 850 as an average molecular mass
for triacylglycerol to obtain the results in g lipid. The factor
075 takes into account the fraction of VLDL-fatty acids
(25 %) that are essential fatty acids and thus cannot be
synthesised de novo (Hudgins et al. 1996). Total hepatic
DNL calculated in this way was multiplied by 133 to correct
for less than complete isotopic equilibration due to the
relatively short time of isotope administration (L Hudgins,
M Hellerstein, R Neese, J Hirsch, unpublished results). No
correction was attempted for the probably lower contribution of DNL to fatty acids other than palmitate.
Blood glucose, insulin and leptin. The plasma used for
the study of hepatic DNL was also used for determination of
glucose (Kunst et al. 1984), insulin and leptin by radioimmunoassays according to the protocol of the manufacturer
(Coat-A-Countt Insulin, Diagnostic Products Corporation,
Los Angeles, CA, USA and Linco Research Inc., St Charles,
MO, USA).
Statistical procedures
Results are presented as mean values with standard errors of
the means, and P -values were calculated by Student's t test
Carbohydrate
intake (MJ/d)
C-group
F-group
C-group
F-group
C-group
F-group
C-group
F-group
C-group
F-group
Pair 1
Pair 2
Pair 3
Pair 4
Pair 5
Pair 6
Pair 7
Pair 8
Pair 9
Pair 10
186
152
122
122
89
135
151
103
144
162
185
152
145
156
112
130
114
103
201
139
93
89
63
70
51
71
104
50
83
87
87
69
61
68
55
69
59
41
112
68
50
40
45
34
22
44
27
25
40
41
02
48
36
64
32
39
38
20
66
37
20
20
16
15
11
17
20
12
16
21
21
26
14
24
13
17
15
10
23
21
22
03
11
02
05
02
00
16
06
13
08
15
35
00
13
04
02
31
00
14
Mean
137
09
144
09
76
05
69
06
37
03
38
06
17
01
18
02
08
02
12
04
SEM
* Phase 1 (prephase) lasted 1014 d. For details of measurement of energy intake see pp. 234235.
Subjects (n 20) were paired according to habitual activity and body size. For details of subjects see Table 1.
237
Table 3. Total intake per day of energy, carbohydrate, fat, protein and alcohol in phase 3 and increase in energy intake from phase 1 to phase 3
(DEnergy)*
Carbohydrate
(MJ/d)
Energy (MJ/d)
Subjects
Fat (MJ/d)
Protein (MJ/d)
Alcohol (MJ/d)
DEnergy (MJ/d)
C-group
F-group
C-group
F-group
C-group
F-group
C-group
F-group
C-group
F-group
C-group
F-group
Pair 1
Pair 2
Pair 3
Pair 4
Pair 5
Pair 6
Pair 7
Pair 8
Pair 9
Pair 10
230
207
157
193
168
194
202
153
226
198
231
205
146
195
137
188
203
158
255
196
176
155
122
147
118
150
157
119
196
155
72
63
44
56
39
58
62
52
77
58
26
22
17
20
17
21
22
17
25
21
129
115
85
107
82
109
117
87
148
115
24
22
19
20
17
22
22
17
26
21
24
21
16
21
16
21
23
18
28
23
04
07
00
05
00
01
00
00
01
01
04
06
00
07
00
01
01
01
02
00
44
54
36
72
79
58
51
50
82
36
46
54
00
39
25
59
89
55
54
57
Mean
193
08
192
11
150
08
58
03
21
01
109
06
21
01
21
01
02
01
02
01
56
05
48
07
SEM
* Phase 1 (prephase) lasted 1014 d; phase 3 (intervention period) lasted 21 d. For details of measurement of energy intake in phase 1 see pp. 234235. In phase 3,
energy intake was intended to be increased by 5 MJ above habitual intake as determined in phase 1 (see pp. 234235).
Subjects (n 20) were paired according to habitual activity and body size. For details of subjects see Table 1. For details of C- and F-group diets in phase 3 see pp.
234235.
mass and total body water were calculated from the daily
measurements of weight and impedance by linear regression
analysis (Table 4). The C- and the F-group showed a
signicant increase in body weight and fat mass of about
similar size, 15 and 09 kg respectively, with no statistically
signicant differences between the groups. A signicant
change of fat free mass was only observed in the C-group.
No changes were observed in total body water.
Mean values of the changes in fat mass and fat free mass
determined by weekly underwater weighing are also given
in Table 4. These values were similar to those obtained by
impedance measurements, although gains in fat free mass
Table 4. Changes in body composition (body weight, fat free mass, fat mass, and total body water) in phase 3
(intervention phase) using impedance and hydrostatic measurements
DBody weight (kg)
Subjects
C-group
F-group
Impedance measurements
Pair 1
225
324
Pair 2
234
348
Pair 3
-010*
163
Pair 4
258
291
Pair 5
-073*
-071
Pair 6
-059*
133*
Pair 7
140
200
Pair 8
205
-006*
Pair 9
112
076*
Pair 10
317
122
Mean
SEM
135
042
0010
Hydrostatic measurements
Mean
SEM
158
041
0006
C-group
F-group
C-group
F-group
C-group
108
150
-002
125
-079
008
-003
107
049
151
151
161
046
125
-109
075
050
-011
032
043
117
084
012*
133
006*
-066*
142
098
064
166
173
187
117
166
038
058*
150
006*
108
079
103
101
-025
095
-046
-025
000
105
027
128
061
023
0030
050
025
0090
076
022
0009
108
019
0001
133
033
085
028
086
049
083
032
046
020
0060
F-group
113
109
015
099
-057
034
000
-004
004
061
037
017
0070
238
O. Lammert et al.
Table 5. Sleeping energy expenditure in phase 2 and in phase 3 (intervention phase)*
Energy expenditure (kJ/h)
Direct method
C-group
Subjects
Indirect method
F-group
C-group
F-group
Phase 2
Phase 3
Phase 2
Phase 3
Phase 2
Phase 3
Phase 2
Phase 3
Pair 1
Pair 2
Pair 3
Pair 4
Pair 5
Pait 6
Pair 7
Pair 8
Pair 9
Pair 10
320
356
446
277
295
410
378
nd
342
277
364
320
nd
274
302
342
346
302
338
299
392
270
266
292
313
346
313
nd
389
320
396
274
nd
302
313
342
320
338
320
328
486
407
299
342
328
418
364
nd
364
310
403
396
331
396
342
396
353
331
374
346
324
320
349
353
331
374
346
nd
371
317
346
335
328
367
324
367
331
353
342
338
Mean
345
20
321
10
322
15
326
11
368
20
367
10
343
7
343
5
SEM
Respiratory quotient
The calculated RQ of food, the measured RQ during sleep,
and the calculated non-protein RQ are given in Table 6.
Food RQ was slightly higher than the measured RQ during
phase 3, both for the period as a whole and if comparisons
were performed separately for week 1, 2 or 3 (data not
shown). As expected, RQ was higher for the C-group than
for the F-group. The measured values for RQ were stable
from night-to-night and decreased on average by 001 (P ,
0004) during the night, when compared hour-by-hour.
Energy expenditure
Mean SEE was measured by direct and indirect calorimetry
and shown in Table 5. No changes over time in energy
expenditure could be observed neither in the C-group nor in
the F-group as a result of overfeeding (phase 2 v. phase 3).
Direct and indirect measurements of energy expenditure in
the experimental period were in agreement in the F-group,
but in the C-group the results obtained by the indirect
method were about 15 % higher in both phase 2 and phase
3 (P , 0002).
Table 6. Respiratory quotients (RQ) in phase 3 (intervention phase) of ingested food, during
sleep and during sleep corrected for protein oxidation*
RQ (food)
Subjects
RQ (sleep)
Non-protein RQ
C-group
F-group
C-group
F-group
C-group
F-group
Pair 1
Pair 2
Pair 3
Pair 4
Pair 5
Pair 6
Pair 7
Pair 8
Pair 9
Pair 10
093
093
094
093
094
094
094
094
094
093
080
080
080
080
080
080
080
081
080
081
089
089
086
080
082
079
088
086
090
094
080
082
080
075
075
074
078
075
080
081
090
090
087
079
082
078
089
087
091
096
079
082
079
073
073
073
076
073
079
081
Mean
094
0001
080
0001
086
001
078
001
087
002
077
001
SEM
239
Table 7. Loss in faeces of energy, dry matter, carbohydrate, fat and nitrogen during phase 3 (intervention phase)*
Energy (MJ/d)
Subjects
Carbohydrate (g/d)
Fat (g/d)
Protein (g/d)
C-group
F-group
C-group
F-group
C-group
F-group
C-group
F-group
C-group
F-group
Pair 1
Pair 2
Pair 3
Pair 4
Pair 5
Pair 6
Pair 7
Pair 8
Pair 9
Pair 10
205
186
132
171
123
166
166
143
180
135
186
112
097
166
075
132
147
096
125
102
9700
8367
5967
7748
5390
7243
7638
6790
8219
6338
7462
4662
4071
6286
3200
5195
6100
4305
5538
4290
6124
4881
3200
3276
2852
3829
4386
4276
4819
3667
3710
2171
1990
2500
1562
2205
2914
2271
3052
2090
876
1205
729
1800
886
1224
824
576
1014
495
2129
1010
838
2143
581
1448
1343
543
829
900
2702
2279
2039
2668
1647
2192
2430
1933
2384
2178
1621
1479
1244
1640
1057
1542
1846
1488
1659
1299
Mean
161
008
124
011
7340
404
5111
399
4131
310
2447
196
963
120
1176
184
2245
103
1488
073
SEM
and F-group respectively (Table 9, column 1). The timecourse of DNL in phase 3 is shown in Table 10. In the Cgroup, fractional hepatic DNL increased within the rst
week and remained at about 20 % for the rest of the period.
The fractional hepatic DNL in phase 2 was generally low
except for C7, C10 and F10 (Table 10). These high values
are not explicable by a habitual diet high in carbohydrate,
except perhaps for C7 (Table 2), but may reect large interindividual differences in hepatic lipogenesis (Aarsland et al.
1996).
Absolute hepatic DNL was estimated from the rate
constant (K s) for VLDL synthesis as determined by the rate
of [1- 13C]acetate incorporation in VLDL palmitate, the fractional hepatic DNL, and the plasma concentration of VLDLtriacylglycerol. K s was 0304 (SEM 0051) h -1 as measured
for C7 to C10 at the end and for C10 at the start of phase 3.
This value was also used for the calculation of absolute
DNL for C2 to C6. Furthermore, a constant rate of hepatic
DNL equal to the rate in the measurement period (10.00
21.00 hours) was assumed throughout the day. Calculated in
Table 8. Nitrogen intake, loss in faeces and urine and nitrogen balance in phase 3 (intervention phase)*
Food nitrogen
intake (g/d)
Subjects
Faeces nitrogen
loss (g/d)
Urine nitrogen
loss (g/d)
N balance
(g/d)
C-group
F-group
C-group
F-group
C-group
F-group
C-group
F-group
Pair 1
Pair 2
Pair 3
Pair 4
Pair 5
Pair 6
Pair 7
Pair 8
Pair 9
Pair 10
223
207
175
191
160
202
210
161
244
194
225
200
155
200
155
196
214
173
262
213
43
37
33
38
26
35
39
31
38
35
26
24
20
26
17
25
30
24
27
21
113
134
94
119
120
124
116
98
150
113
150
143
117
146
120
136
121
115
187
142
58
28
41
26
07
35
47
26
46
38
41
25
12
20
12
27
55
27
38
41
Mean
197
08
199
10
36
02
24
01
118
05
138
07
35
05
30
04
SEM
55
96
2328
118
33
F1F10
Mean
56
2878
432
514
158
91
202
56
96
12
101
14
20
15
Mean
SEM
7
21
76
11
553
26
254
38
360
109
180
133
-122
686
-09
-277
394
316
-73
353
377
269
178
-52
36
-37
284
150
377
437
88
120
73
180
89
122
82
58
101
50
nd
136
89
88
67
130
184
113
51
46
245
281
196
220
116
204
200
192
130
209
nd
40
49
17
34
26
189
84
20
173
C1
C2
C3
C4
C5
C6
C7
C8
C9
C10
Phase 3
Subjects
Phase 2
nd
102
67
66
51
98
139
85
38
34
687
592
455
534
454
563
586
447
651
558
222
202
204
406
330
478
219
239
173
71
557
402
56
634
27
-315
678
466
304
790
DNL total
(g/d)
phase 3
Exogenous fat
for storage (g/d)
phase 3
Faecal fat
loss (g/d)
phase 3
DNL, hepatic
absolute (g/d)
phase 3
Fat intake
(g/d)
phase 3
Fat oxidized
(g/d)
phase 3
Fat mass
increase (g/d)
phase 3
DNL, hepatic
absolute (g/d)
phase 3
DNL, hepatic
fractional (%)
Table 9. Fractional and absolute hepatic de novo lipogenesis (DNL) and calculation of total and extrahepatic lipogenesis*
nd
-03
-211
597
-77
-407
210
203
-124
308
O. Lammert et al.
DNL extrahepatic
(g/d)
phase 3
240
Phase 2
Week 1
Week 2
Week 3
C2
C3
C4
C5
C6
C7
C8
C9
C10
40
49
17
34
26
189
84
20
173
215
210
122
80
189
182
183
159
179
320
142
291
166
294
187
251
124
243
195
236
246
103
129
232
144
108
204
F2
F3
F4
F5
F6
F7
F8
F9
F10
93
28
42
23
16
18
30
61
196
28
23
34
10
19
14
06
09
24
33
35
47
04
21
16
07
40
25
22
38
61
09
25
20
00
45
97
2 (fasting values 108 (SEM 018) and 188 (SEM 030), and
non-fasting values 164 (SEM 030) and 211 (SEM 029)
respectively, P = 0007 and 00006 respectively). The corresponding values for the F-group were 146 (SEM 012) and
107 (SEM 022), and 207 (SEM 022) and 195 (SEM 033)
respectively, i.e. no signicant changes from phase 2 to
phase 3.
Glucose, insulin and leptin
Fasting and non-fasting glucose concentrations were within
the range of 4551 and 4852 mmol/ml plasma respectively. No signicant differences between the C- and the
F-group or between phase 2 and phase 3 were observed.
The fasting and non-fasting insulin concentrations were
912 and 2331 mU/ml plasma respectively. No signicant
differences between the C- and the F-group or between
phase 2 and phase 3 were observed.
Leptin concentration in each subject was calculated as the
mean value of measurements at 10.00, 18.00, 19.00, 20.00
and 21.00 hours in order to eliminate the effects of diurnal
variation. The leptin concentration (ng/ml plasma) in the Cgroup was 24 (SEM 02) in phase 2 and increased signicantly (P = 0028) in the intervention period to 32 (SEM 04).
In the F-group the phase 2 values were similar to those of the
C-group (25 (SEM 03)) but no signicant changes could be
observed in phase 3 (28 (SEM 03) at the end of phase 3).
When data from both groups were pooled a signicant
positive correlation (P = 00046) was observed between
the increase in fat mass and the concentration of leptin
(Fig. 1). This is in agreement with the ndings of Considine
et al. (1996), who found a strong positive correlation
241
Fig. 1. Correlation between change in fat mass and change in plasma leptin concentration in normal male subjects (n 18) overfed by approximately
5 MJ/d for 21 d (y = 079x - 010, r 2 040, P , 0005). For details of subjects see Table 1. Fat mass and leptin concentrations were determined as
described on pp. 234235. Leptin was not measured in two subjects (C1 and F1).
242
O. Lammert et al.
243
244
O. Lammert et al.
Bennett C, Reed GW, Peters JC, Abumrad NN, Sun M & Hill JO
(1992) Short-term effects of dietary-fat ingestion on energy
expenditure and nutrient balance. American Journal of Clinical
Nutrition 55, 10711077.
Bingham S & Cummings JH (1985) Urine nitrogen as an independent validatory measure of dietary intake: a study of nitrogen
balance in individuals consuming their normal diet. American
Journal of Clinical Nutrition 42, 12761289.
Bouchard C, Tremblay A, Despres JP, Nadeau A, Lupien PJ,
Theriault G, Dussault J, Moorjani S, Pinault S & Fournier G
(1990) The response to long-term overfeeding in identical twins.
New England Journal of Medicine 332, 14771482.
Clore JN, Helm ST, & Blackward WG (1995) Loss of hepatic
autoregulation after carbohydrate overfeeding in man. Journal
of Clinical Investigation 96, 19671972.
Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens
TA, Nyce MR, Ohannesian JP, Marco CC, McKee LJ, Bauer TL
& Caro JF (1996) Serum immunoreactive-leptin concentrations
in normal-weight and obese persons. New England Journal of
Medicine 334, 292295.
Dallosso HM & James WPT (1984) Whole body calorimetry
studies in adult men. British Journal of Nutrition 52, 4964.
Danskernes kostvaner (1996) Levnedsmiddelstyrelsen, Copenhagen.
Davies SP, Carling D, Munday MR & Hardie DG (1992) Diurnal
rhythm of phosphorylation of rat liver acetyl-CoA carboxylase
by the AMP-activated protein kinase, demonstrated using
freeze-clamping. European Journal of Biochemistry 203, 615
623.
Diaz EO, Prentice AM, Goldberg GR, Murgatroyd PR & Coward
WA (1992) Metabolic response to experimental overfeeding in
lean and overweight volunteers. American Journal of Clinical
Nutrition 56, 641655.
Elia M & Livesey G (1992) Energy expenditure and fuel selection
in biological systems: the theory and practice of calculations
based on indirect calorimetry and tracer methods. In Metabolic
Control of Eating, Energy Expenditure and the Bioenergetics of
Obesity [AP Simopoulos, editor]. World Review of Nutrition and
Dietetics 70, 68131.
Faber P, Lammert O, Johansen O & Garby L (1998) A fast
combined direct and indirect calorimeter for human subjects.
Medical Engineering & Physics 20, 291301.
Faix D, Neese R, Kletke C, Wolden S, Cesar D, Soutlangus M,
Shackleton CHL & Hellerstein MK (1993) Quantication of
menstrual and diurnal periodicities in rates of cholesterol and
fat synthesis in humans. Journal of Lipid Research 34, 2063
2075.
Flatt JP (1978) The biochemistry of energy expenditure. Recent
Advances in Obesity Research 2, 211228.
Flatt JP (1987) The difference in storage capacities for carbohydrate and for fat, and its implications in the regulation of body
weight. Annals of the New York Academy of Sciences 499, 104
123.
Flatt JP (1995) Body composition, respiratory quotient, and weight
maintenance. American Journal of Clinical Nutrition 62,
1107S1117S.
Forbes G, Brown MR, Welle SL & Lipinski BA (1986) Deliberate
overfeeding in women and men: energy cost and composition of
the weight gain. British Journal of Nutrition 56, 19.
Golay A, Allaz AF, Morel Y, de Tonnac N, Tankowa S & Reaven
G (1996) Similar weight loss with low- or high-carbohydrate
diets. American Journal of Clinical Nutrition 63, 174178.
Goldberg GR, Black AE, Jebb SA, Cole TJ, Murgatroyd PR,
Coward WA & Prentice AM (1991) Critical evaluation of
energy intake data using fundamental principles of energy
physiology: 1. Derivation of cut-off limits to identify underrecording. European Journal of Clinical Nutrition 45, 569
581.
245